KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Divestments (2021 - 2022)

Historic Divestments for Biogen (BIIB) over the last 5 years, with Q4 2025 value amounting to $56.7 million.

  • Biogen's Divestments changed N/A to $56.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $56.7 million, marking a year-over-year change of. This contributed to the annual value of $56.7 million for FY2025, which is 8606.19% down from last year.
  • According to the latest figures from Q4 2025, Biogen's Divestments is $56.7 million.
  • Biogen's 5-year Divestments high stood at $990.3 million for Q2 2022, and its period low was -$63.1 million during Q2 2021.
  • For the 3-year period, Biogen's Divestments averaged around $228.1 million, with its median value being $65.4 million (2021).
  • The largest annual percentage gain for Biogen's Divestments in the last 5 years was 166941.36% (2022), contrasted with its biggest fall of 166941.36% (2022).
  • Biogen's Divestments (Quarter) stood at $65.4 million in 2021, then surged by 1414.22% to $990.3 million in 2022, then crashed by 94.27% to $56.7 million in 2025.
  • Its Divestments stands at $56.7 million for Q4 2025, versus $990.3 million for Q2 2022 and $65.4 million for Q4 2021.